Advertisement

Psychopharmacology

, Volume 182, Issue 2, pp 262–276 | Cite as

The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory

  • Catharine Montgomery
  • John E. FiskEmail author
  • Russell Newcombe
  • Phillip N. Murphy
Original Investigation

Abstract

Rationale/Objectives

Recent theoretical models suggest that the central executive may not be a unified structure. The present study explored the nature of central executive deficits in ecstasy users.

Methods

In study 1, 27 ecstasy users and 34 non-users were assessed using tasks to tap memory updating (computation span; letter updating) and access to long-term memory (a semantic fluency test and the Chicago Word Fluency Test). In study 2, 51 ecstasy users and 42 non-users completed tasks that assess mental set switching (number/letter and plus/minus) and inhibition (random letter generation).

Results

MANOVA revealed that ecstasy users performed worse on both tasks used to assess memory updating and on tasks to assess access to long-term memory (C- and S-letter fluency). However, notwithstanding the significant ecstasy group-related effects, indices of cocaine and cannabis use were also significantly correlated with most of the executive measures. Unexpectedly, in study 2, ecstasy users performed significantly better on the inhibition task, producing more letters than non-users. No group differences were observed on the switching tasks. Correlations between indices of ecstasy use and number of letters produced were significant.

Conclusions

The present study provides further support for ecstasy/polydrug-related deficits in memory updating and in access to long-term memory. The surplus evident on the inhibition task should be treated with some caution, as this was limited to a single measure and has not been supported by our previous work.

Keywords

Ecstasy MDMA Cannabis Cocaine Memory updating Switching Inhibition Executive function 

References

  1. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW (2003) Stop-signal inhibition disrupted by damage to the right inferior frontal gyrus in humans. Nat Neurosci 6:115–116CrossRefPubMedGoogle Scholar
  2. Baddeley AD (1996) Exploring the central executive. Q J Exp Psychol 49A:5–28CrossRefGoogle Scholar
  3. Bhattachary S, Powell JH (2001) Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or “ecstasy”: evidence for cognitive impairment. Psychol Med 31:647–658CrossRefPubMedGoogle Scholar
  4. Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA (“ecstasy”) users. Neurology 51:1532–1537PubMedGoogle Scholar
  5. Casey BJ, Trainor RJ, Orendi JL, Schubert AB, Nystrom LE, Giedd JN, Castellanos FX, Haxby JV, Noll DC, Forman SD, Dahl RE, Rapoport JL (1997) A developmental functional MRI study of prefrontal activation during performance of a go/no-go task. J Cogn Neurosci 9:835–847CrossRefGoogle Scholar
  6. Cohen Z, Bonvento G, Lacombe P, Hamel E (1996) Serotonin in the regulation of brain microcirculation. Prog Neurobiol 50:335–362CrossRefPubMedGoogle Scholar
  7. Cole J, Bailey M, Sumnall HR, Wagstaff GF, King LA (2002a) The content of ecstasy tablets: implications for the study of their long-term effects. Addiction 97:1531–1536CrossRefPubMedGoogle Scholar
  8. Cole J, Sumnall H, Grob C (2002b) Sorted: ecstasy facts and fiction. Psychologist 15(9):464–467Google Scholar
  9. Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J, Haga E, Vimal RLP, Lukas SE, Renshaw PF (2003) Reduced cortical gray matter density in human MDMA (ecstasy) users: a voxel-based morphometry study. Drug Alcohol Depend 72:225–235CrossRefPubMedGoogle Scholar
  10. Croft RJ, Mackay AJ, Mills ATD, Gruzelier JGH (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153:373–379CrossRefPubMedGoogle Scholar
  11. Curran HV, Travill RA (1997) Mood and cognitive deficits of 3,4-methylenedioxymethamphetamine (MDMA “ecstasy”): weekend “high” followed by mid-week low. Addiction 92:821–831CrossRefPubMedGoogle Scholar
  12. Curran HV, Verheyden SL (2003) Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Psychopharmacology 169(1):91–103CrossRefPubMedGoogle Scholar
  13. Fisk JE, Sharp C (2004) Age-related impairment in executive functioning: updating, inhibition, shifting, and access. J Clin Exp Neuropsychol 26Google Scholar
  14. Fisk JE, Warr P (1996) Age and working memory: the role of perceptual speed, the Central Executive and the phonological loop. Psychol Aging 11(2):316–323CrossRefPubMedGoogle Scholar
  15. Fisk JE, Montgomery C, Murphy P, Wareing M (2004) Evidence of executive deficits among users of MDMA (Ecstasy). Br J Psychol 95:457–466CrossRefPubMedGoogle Scholar
  16. Fox HC, Parrot AC, Turner JJD (2001) Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. J Psychopharmacol 15:273–281PubMedGoogle Scholar
  17. Fox HC, McLean A, Turner JJD, Parrott AC, Rogers R, Sahakian BJ (2002) Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (“ecstasy”) polydrug users. Psychopharmacology 162:203–214CrossRefPubMedGoogle Scholar
  18. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonesca F, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signalling in the dorsal striatum. Nat Neurosci 2:358–363CrossRefPubMedGoogle Scholar
  19. Goldman-Rakic PS (1996) The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philos Trans R Soc Lond 351:1445–1453CrossRefGoogle Scholar
  20. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HK, Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719–725CrossRefPubMedGoogle Scholar
  21. Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J (2001) Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy. Hum Psychopharm Clin Exp 16(8):607–612CrossRefGoogle Scholar
  22. Hinkle DE, Wiersma W, Jurs SG (1994) Applied statistics for the behavioral sciences, 3rd edn. Houghton Mifflin, BostonGoogle Scholar
  23. Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH (2003) Preliminary evidence of hippocampal dysfunction in adolescent MDMA (‘ecstasy’) users: possible relationship to neurotoxic effects. Psychopharmacology 173:383–390CrossRefPubMedGoogle Scholar
  24. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14:540–545PubMedGoogle Scholar
  25. Kiefer M, Marzinzik F, Weisbrod M, Scherg M, Spitzer M (1998) The time course of brain activations during response inhibition: evidence from event-related potentials in a go/no-go task. NeuroReport 9:765–770PubMedCrossRefGoogle Scholar
  26. Kish SJ (2002) How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav 71:845–855CrossRefPubMedGoogle Scholar
  27. Klugman A, Hardy S, Baldeweg T, Gruzelier J (1999) Toxic effect of MDMA on brain serotonin neurons. Lancet 353:1269–1270CrossRefPubMedGoogle Scholar
  28. Kolb B, Whishaw IQ (1985) Fundamentals of human neuropsychology, 2nd edn. WH Freeman, New YorkGoogle Scholar
  29. Lehto J (1996) Are executive function tests dependent on working memory capacity? Q J Exp Psychol A 49:29–50CrossRefGoogle Scholar
  30. Levin HS, Song J, Ewing-Cobbs L, Chapman SB, Mendelsohn D (2001) Word fluency in relation to severity of closed head injury, associated frontal brain lesions, and age at injury in children. Neuropsychologia 39(2):122–131CrossRefPubMedGoogle Scholar
  31. Liechti ME, Gamma A, Vollenweider FX (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology 154:161–168CrossRefPubMedGoogle Scholar
  32. McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after 3,4-methylenedioxymethamphetamine (MDMA; ecstasy): a controlled study in humans. Neuropsychopharmacology 10:129–138PubMedGoogle Scholar
  33. McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C (2004) Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology 173(3–4):434–439CrossRefPubMedGoogle Scholar
  34. McDowell DM, Kleber HD (1994) MDMA: its history and pharmacology. Psychiatr Ann 24:127–130Google Scholar
  35. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD (2000) The unity and diversity of executive functions, and their contributions to complex “frontal lobe” tasks: a latent variable analysis. Cogn Psychol 41(1):49–100CrossRefPubMedGoogle Scholar
  36. Montgomery C, Fisk JE, Newcombe R (2004) Further evidence for deficits in the updating executive component process of working memory in users of MDMA (Ecstasy). Proc Br Psychol Soc 12:70Google Scholar
  37. Montgomery C, Fisk JE, Newcombe R, Wareing M, Murphy PN (2005) Syllogistic reasoning performance in MDMA (ecstasy) users. Exp Clin Psychopharmacol 13Google Scholar
  38. Montgomery C, Fisk JE, Newcombe R (in press) The nature of ecstasy-group related differences in associative learning. PsychopharmacologyGoogle Scholar
  39. Morgan MJ (1998) Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252–264CrossRefPubMedGoogle Scholar
  40. Morgan MJ (1999) Memory deficits associated with recreational use of “ecstasy” (MDMA). Psychopharmacology 141:30–36CrossRefPubMedGoogle Scholar
  41. Morgan MJ, McFie L, Fleetwood LH, Robinson JA (2002) Ecstasy (MDMA): are the psychological problems associated with it's use reversed by prolonged abstinence? Psychopharmacology 159:294–303CrossRefPubMedGoogle Scholar
  42. Morris N, Jones DM (1990) Memory updating in working memory: the role of the central executive. Br J Psychol 81:111–121Google Scholar
  43. Moulden DJA, Picton TW, Meiran N, Stuss DT, Riera JJ, Valdes-Sosa P (1998) Event-related potentials when switching attention between task-sets. Brain Cogn 37:186–190Google Scholar
  44. Nelson HE (1982) National Adult Reading Test (NART) test manual. NFER-Nelson, Windsor, BerkshireGoogle Scholar
  45. Ng Cheong Ton JM, Gardner EL (1986) Effects of delta-9-tetrahydrocannabinol on dopamine release in the brain: intracranial microdialysis experiments. Soc Neurosci Abstr 13:135Google Scholar
  46. Parrot AC (2000) Human research on MDMA (3,4-methylene-dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change. Neuropsychobiology 42:17–24CrossRefPubMedGoogle Scholar
  47. Parrot AC (2004) Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology (Berl) 173(3–4):234–241CrossRefGoogle Scholar
  48. Posner MI, Raichle ME (1994) Images of mind. Scientific American, New YorkGoogle Scholar
  49. Raven J, Raven JC, Court JH (1998) Manual for Raven's Progressive Matrices and Vocabulary Scales. Oxford Psychologists Press, OxfordGoogle Scholar
  50. Reneman L, Majoie CBLM, Schmand B, van den Brink W, den Heeten GJ (2001) Pre-frontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biol Psychiatr 50:550–554CrossRefGoogle Scholar
  51. Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning BW, den Heeten GJ, van der Brink W (2002) Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study—preliminary report. Psychopharmacology (Berl) 159:335–340CrossRefGoogle Scholar
  52. Ricaurte GA, McCann UD (1992) Neurotoxic amphetamine analogues: effects in monkeys and implications for humans. Ann N Y Acad Sci 648:371–382PubMedCrossRefGoogle Scholar
  53. Ricaurte GA, Yuan J, McCann UD (2000) (+/−)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42(1):5–10CrossRefPubMedGoogle Scholar
  54. Rodgers J (2000) Cognitive performance amongst recreational users of “ecstasy”. Psychopharmacology 151:19–24CrossRefPubMedGoogle Scholar
  55. Rogers RD, Monsell S (1995) Costs of a predictable shift between simple cognitive tasks. J Exp Psychol Gen 124:207–231CrossRefGoogle Scholar
  56. Rogers RD, Sahakian BJ, Hodges JR, Polkey CE, Kennard C, Robbins TW (1998) Dissociating executive mechanisms of task control following frontal lobe damage and parkinson's disease. Brain 121:815–842CrossRefPubMedGoogle Scholar
  57. Ruff RM, Light RH, Parker SB, Levin HS (1997) The psychological construct of word fluency. Brain Lang 57:394–405CrossRefPubMedGoogle Scholar
  58. Salthouse TA, Babcock RL (1991) Decomposing adult age differences in working memory. Dev Psychol 27:763–776CrossRefGoogle Scholar
  59. Sankoh AJ, Huque MF, Dubey SD (1997) Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 16:2529–2542CrossRefPubMedGoogle Scholar
  60. Solowij N, Hall W, Lee N (1992) Recreational MDMA use in Sydney: a profile of ‘Ecstacy’ users and their experiences with the drug. Br J Addict 87(8):1161–1172PubMedCrossRefGoogle Scholar
  61. Solowij N, Stephens RS, Roffman RA, Kadden T, Miller R, Christiansen M, McRee K, Vendetti B (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. J Am Med Assoc 287:1123–1131CrossRefGoogle Scholar
  62. Strickland TL, Mena I, Villanueva-Meyer J, Miller BL, Cummings J, Mehringer CM, Satz P, Myers H (1993) Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 5(4):419–427PubMedGoogle Scholar
  63. Stuss DT, Alexander MP, Hamer L, Palumbo C, Dempster R, Binns M, Levine B, Izukava D (1998) The effects of focal anterior and posterior brain lesions on verbal fluency. J Int Neuropsychol Soc 4:265–278PubMedGoogle Scholar
  64. Thomasius R, Petersen K, Buchert R, Andersen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167(1):85–96PubMedGoogle Scholar
  65. Turner JJD, Godolphin M, Parrot AC (1999) Cognitive performance profiles of current and former “ecstasy” (MDMA) users. J Psychopharmacol 13:A24Google Scholar
  66. Van der Linden M, Collette F, Salmon E, Delfiore G, Delgueldre C, Luxen A, Franck G (1999) The neural correlates of updating information in verbal working memory. Memory 7:549–560CrossRefPubMedGoogle Scholar
  67. Verdejo-Garcia AJ, Lopez-Torrecillas F, de Arcos AF, Perez-Garcia M (2005) Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance abusers: a multiple regression analysis. Addict Behav 30:89–101CrossRefPubMedGoogle Scholar
  68. Verheul R (2001) Co-morbidity of personality disorders in individuals with substance use disorders. Eur Psychiatr 16:274–282CrossRefGoogle Scholar
  69. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D et al (2001) Association of Dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377–382PubMedCrossRefGoogle Scholar
  70. Von Geusau NA, Stalenhoef P, Huizinga M, Snel J, Ridderinkhof KR (2004) Impaired executive function in male MDMA (“ecstasy”) users. Psychopharmacology 175:331–341CrossRefGoogle Scholar
  71. Wareing M, Fisk JE, Murphy P (2000) Working memory deficits in current and previous users of MDMA (“ecstasy”). Br J Psychology 91:181–188CrossRefGoogle Scholar
  72. Wareing M, Fisk JE, Murphy P, Montgomery C (2004a) Verbal working memory deficits in current and previous users of MDMA. Hum Psychopharmacol Clin Exp 19:225–234CrossRefGoogle Scholar
  73. Wareing M, Murphy P, Fisk JE (2004b) Visuospatial memory impairments in users of MDMA (‘ecstasy’). Psychopharmacology 173:391–397CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Catharine Montgomery
    • 1
  • John E. Fisk
    • 1
    Email author
  • Russell Newcombe
    • 1
  • Phillip N. Murphy
    • 2
  1. 1.School of PsychologyLiverpool John Moores UniversityLiverpoolUK
  2. 2.Edge Hill College of Higher EducationLancashireUK

Personalised recommendations